Platelet-Derived Growth Factor CC — A Clinically Useful Angiogenic Factor at Last?
- 28 April 2005
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (17) , 1815-1816
- https://doi.org/10.1056/nejmcibr050670
Abstract
A member of the platelet-derived growth factor family (PDGF-CC) is necessary and sufficient to induce neovascularization in two models of ischemia.Keywords
This publication has 5 references indexed in Scilit:
- Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitorsJournal of Clinical Investigation, 2004
- Vascular frontiers without borders: Multifaceted roles of platelet-derived growth factor (PDGF) in supporting postnatal angiogenesis and lymphangiogenesisCancer Cell, 2004
- Insight into the physiological functions of PDGF through genetic studies in miceCytokine & Growth Factor Reviews, 2004
- Therapeutic Angiogenesis and Vasculogenesis for Ischemic DiseaseCirculation, 2004
- Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2Nature Medicine, 2003